Physician profile
John E Milner
NPI 1164589776
$1,705.23
in general payments reported to CMS, 2019-2025
31 companies · $574 in 2025
The $574 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $14.15 · 2021: $18.77 · 2022: $225 · 2023: $192 · 2024: $535 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $181.68 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Procept Biorobotics Corporation | $134.06 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Novartis Pharmaceuticals Corporation | $118.77 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $107.10 | 2025 | Trelstar, Tlando |
| Teleflex LLC | $101.55 | 2024-2025 | Urolift, Barrigel |
| Olympus America INC. | $96.96 | 2020-2023 | Itind System, Olympus |
| Antares Pharma, INC. | $95.27 | 2024-2025 | Xyosted |
| Abbvie INC. | $90.54 | 2022-2025 | |
| Pfizer INC. | $82.66 | 2019-2025 | |
| Urogen Pharma, INC. | $79.32 | 2023-2025 | Jelmyto |
| Urovant Sciences INC | $58.57 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.91 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $55.61 | 2023-2024 | Lynparza, Keytruda |
| Accord Healthcare, INC. | $51.72 | 2022-2024 | |
| Immunitybio, INC. | $39.51 | 2024-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $37.94 | 2025 | Evarrest, Surgiflo Hemostatic Matrix, Surgicel Nu-Knit |
| Janssen Biotech, INC. | $29.37 | 2025 | Erleada |
| Ferring Pharmaceuticals INC. | $28.76 | 2025 | Adstiladrin |
| Laborie Medical Technologies Corp. | $26.37 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Dendreon Pharmaceuticals LLC | $25.41 | 2025 | Provenge |
| Sun Pharmaceutical Industries INC. | $23.01 | 2024 | |
| Becton, Dickinson and Company | $22.83 | 2023 | Bard Urinary Drainage Bag |
| Convatec INC. | $21.71 | 2024 | |
| Abbott Laboratories | $21.67 | 2024 | Proclaim |
| Mimedx Group, INC. | $19.58 | 2025 | |
| Profound Medical Corp. | $19.36 | 2025 | Tulsa-Pro |
| 180 Medical, INC. | $18.81 | 2024 | |
| Abc Home Medical Supply, INC. | $18.38 | 2024 | |
| Hollister Incorporated | $17.08 | 2022 | |
| Sumitomo Pharma America, INC. | $13.23 | 2023 | Gemtesa |
| Myriad Genetic Laboratories, INC. | $11.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Milner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.